Omid Hamid, MD
Hematology & Oncology · Santa Monica, CANPI 1215966775
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 33.1% of the total. Among hematology & oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 512 payments — averaging $1581.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$268K
- Regeneron Healthcare Solutions, Inc.$91K
- Novartis$74K
- Merck$71K
- Immunocore Limited$54K
- Array Biopharma Inc$52K
- plus $200K from 25 others
Across 3,745 payments — averaging $6137.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$6.3M
- Merck$5.4M
- Regeneron$2.2M
- Novartis$1.3M
- GSK$1.1M
- AstraZeneca$1M
- plus $5.6M from 24 others
What the payments were for
- Consulting fees$258,23232%
- Speaking & faculty fees$460,15057%
- Travel & lodging$81,29210%
- Food & beverage$9,2381%
- Education$5650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 147 | $268,221 |
| Regeneron Healthcare Solutions, Inc. | 59 | $90,707 |
| Novartis | 44 | $73,577 |
| Merck | 56 | $71,370 |
| Immunocore Limited | 38 | $53,692 |
| Array Biopharma Inc | 46 | $51,904 |
| Regeneron | 27 | $43,533 |
| Pfizer | 18 | $30,666 |
| Sanofi | 21 | $28,200 |
| Janssen Global Services, LLC | 5 | $21,998 |
| F. Hoffmann-la Roche AG | 6 | $21,199 |
| Sun Pharmaceutical Industries Inc. | 1 | $7,500 |
| Alkermes, Inc. | 6 | $7,162 |
| Incyte Corporation | 4 | $6,544 |
| Bayer | 2 | $6,473 |
| Karyopharm Therapeutics Inc. | 1 | $5,000 |
| Biontech SE | 4 | $4,828 |
| Eisai Inc. | 2 | $4,798 |
| Eisai CO., LTD. | 2 | $3,750 |
| Partner Therapeutics, Inc. | 2 | $2,500 |
| Grifols, S.A. | 2 | $1,750 |
| Seagen Inc. | 1 | $1,650 |
| Kyowa Kirin, Inc. | 1 | $785 |
| Hexal AG | 1 | $600 |
| Genentech, Inc. | 3 | $469 |
| AVEO Pharmaceuticals, Inc. | 4 | $270 |
| EMD Serono, Inc. | 5 | $119 |
| Lilly USA, LLC | 1 | $78 |
| GSK | 1 | $57 |
| Modernatx, Inc. | 1 | $56 |
| Bristol Myers Squibb | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$809,477 in reported general payments places this provider in the 95th percentile of 1,363 hematology & oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocortisone | 21 | $867 |
| Pantoprazole Sodium | 12 | $168 |
| Sodium Chloride0.9 % Sodium Chloride | 12 | $146 |
| Prednisone | 26 | $131 |
| Gabapentin | 16 | $69 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Santa Monica
- Richard FinnSanta Monica$784K
- Zev WainbergSanta Monica$761K
- Saeed SadeghiSanta Monica$696K
- Aditya BardiaSanta Monica$593K
- Steven OdaySanta Monica$270K
- Dennis SlamonLos Angeles$3.1M
- Sandra HorningStanford$2.5M
- Mohammadbagher ZiariCorona$2.5M
- George YaghmourLos Angeles$1.9M
- Robert VescioWest Hollywood$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.